RESIST-TB released its May 2020 newsletter with the latest research publications on drug-resistant TB.

RESIST-TB released its March newsletter. The presentation slides and recording of the webinar on the NiX-TB trial, conducted on 26 March 2020, are now available online.

RESIST-TB will host a webinar on 26 March 2020 to discuss the recently published work on the NiX-TB trial, which focuses on treatment of extensively drug-resistant TB (XDR-TB).

New articles highlight emergence of resistance to bedaquiline and underline the need for improved susceptibility testing.

RESIST-TB will host a webinar on approaches for improving inference from observational multidrug-resistant TB (MDR-TB) treatment cohorts on 27 January 2020.

RESIST-TB and The Union’s Nurses and Allied Professionals Sub-Section (NAPS) will host a webinar on 16 January 2019 to discuss the Nursing Guide for Managing Side Effects to Drug-resistant TB Treatment, developed by the Curry International Tuberculosis Center (CITC) and the International Council of Nurses (ICN).

RESIST-TB will host a webinar about the current evidence and practices for the combined use of delamanid and bedaquiline for the treatment of multidrug-resistant TB (MDR-TB) on 5 April 2018.

RESIST-TB will host a webinar: New XDR-TB regimens containing pretomanid on 11 January 2018.

RESIST-TB will host a webinar: STREAM MDR-TB Clinical Trial: Results of Comparison of 9-Month Treatment Regimen to 20-24 Month Regimen on 14 December 2017.

RESIST-TB will host a webinar, LAM (lipoarabinomannan) as a pharmacodynamic biomarker and drug development tool for TB, on 22 June 2017 from 08:30 to 09:30 EST (14:30-15:30 CEST, SAST).